Rise Advisors, LLC Pds Biotechnology Corp Transaction History
Rise Advisors, LLC
- $242 Million
- Q2 2025
A detailed history of Rise Advisors, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Rise Advisors, LLC holds 840 shares of PDSB stock, worth $932. This represents 0.0% of its overall portfolio holdings.
Number of Shares
840
Previous 325
158.46%
Holding current value
$932
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PDSB
# of Institutions
54Shares Held
8.22MCall Options Held
151KPut Options Held
1.2K-
Armistice Capital, LLC New York, NY4.42MShares$4.91 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$1.68 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$540,5330.0% of portfolio
-
Geode Capital Management, LLC Boston, MA418KShares$463,9060.0% of portfolio
-
Ubs Group Ag251KShares$278,7830.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $31.6M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...